Health Canada has granted priority review to Chiesi Global Rare Diseases’ application seeking approval of Filsuvez (birch triterpenes),…
Articles by Andrea Lobo, PhD
Parents reported that oral health problems lead to a poorer quality of life for their children with epidermolysis bullosa…
Low levels of zinc — an essential mineral that supports wound healing — in people with recessive dystrophic epidermolysis…
TCP-25 gel is well-tolerated by individuals with recessive dystrophic epidermolysis bullosa (RDEB) and…
Children’s Hospital Colorado has become a qualified treatment center for Zevaskyn (prademagene zamikeracel), a cell-based gene therapy for…
People living with epidermolysis bullosa (EB) generally reported that Filsuvez (birch triterpenes) had a beneficial effect on wound…
People with severe recessive dystrophic epidermolysis bullosa (RDEB) are more likely to develop disease-related complications, and at a younger…
Abeona Therapeutics is preparing for the potential launch of pz-cel (prademagene zamikeracel) to treat recessive dystrophic epidermolysis…
People with epidermolysis bullosa (EB) experience a deterioration in oral health, which is linked to poor health-related quality of…
Surgical correction followed by continuous compressive bandaging effectively treated hand finger adhesion and contractures in a woman with recessive…
RLF-TD011, an antimicrobial spray, will be granted European Union patent coverage for wound treatment in people with epidermolysis bullosa…
Three types of molecules were found to support the production of collagen VII (C7) in patient-derived cell models of recessive…